Asaf Stolovy - Human Xtensions Chief Officer
| HUMX Stock | ILA 31.80 0.00 0.00% |
Insider
Asaf Stolovy is Chief Officer of Human Xtensions
| Age | 47 |
| Phone | 972 7 363 0300 |
| Web | https://human-x.com |
Human Xtensions Management Efficiency
The company has return on total asset (ROA) of (0.2713) % which means that it has lost $0.2713 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5004) %, meaning that it generated substantial loss on money invested by shareholders. Human Xtensions' management efficiency ratios could be used to measure how well Human Xtensions manages its routine affairs as well as how well it operates its assets and liabilities.Human Xtensions has accumulated 7.55 M in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Human Xtensions has a current ratio of 16.5, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Human Xtensions until it has trouble settling it off, either with new capital or with free cash flow. So, Human Xtensions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Human Xtensions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Human to invest in growth at high rates of return. When we think about Human Xtensions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Eldad Cohen | Analyst IMS Investment | 49 | |
| Ester Levy | Hiron Trade Investments Industr | 58 | |
| Jon MD | Opko Health | 68 | |
| Jacob Atrakchi | Aura Investments | 57 | |
| Alon Eliraz | Harel Insurance Investments | 52 | |
| Elias MD | Opko Health | 72 | |
| Eran Magor | Aura Investments | 47 | |
| James DeMarco | Opko Health | N/A | |
| Nir Kelner | Adgar Investments and | 46 | |
| Noam Rokach | Analyst IMS Investment | 52 | |
| Victor Braha | Analyst IMS Investment | 49 | |
| Neil Amir | Hiron Trade Investments Industr | 37 | |
| Alona Lahav | Aura Investments | 53 | |
| Dorit Zion | Hiron Trade Investments Industr | N/A | |
| Arie Gutman | Opko Health | 69 | |
| Yonatan LeAri | Hiron Trade Investments Industr | 47 | |
| Nataly MishanZakai | Harel Insurance Investments | 49 | |
| Itay Kantrowitz | Adgar Investments and | 59 | |
| Nir Cohen | Harel Insurance Investments | 52 | |
| Liat CPA | Adgar Investments and | 52 | |
| Udi Efron | Adgar Investments and | 49 | |
Management Performance
| Return On Equity | -0.5 | |||
| Return On Asset | -0.27 |
Human Xtensions Leadership Team
Elected by the shareholders, the Human Xtensions' board of directors comprises two types of representatives: Human Xtensions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Human. The board's role is to monitor Human Xtensions' management team and ensure that shareholders' interests are well served. Human Xtensions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Human Xtensions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Asaf Stolovy, Chief Officer | ||
| Amir MD, Chief Officer | ||
| Barak Klein, Chief Officer | ||
| Alon Heth, VP Sales | ||
| Tami Frenkel, CoFounder Director | ||
| Ronen Castro, Chief Officer | ||
| Hagar Lisser, Human Director |
Human Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Human Xtensions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (14.93) % | |||
| Current Valuation | (47.61 M) | |||
| Shares Outstanding | 26.76 M | |||
| Shares Owned By Insiders | 55.22 % | |||
| Shares Owned By Institutions | 9.62 % | |||
| Price To Book | 0.27 X | |||
| Price To Sales | 6.20 X | |||
| Revenue | 3.12 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Human Stock
Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.